These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35019279)

  • 1. Distinct Binding Mechanisms for Allosteric Sodium Ion in Cannabinoid Receptors.
    Dutta S; Selvam B; Shukla D
    ACS Chem Neurosci; 2022 Feb; 13(3):379-389. PubMed ID: 35019279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.
    Ji B; Liu S; He X; Man VH; Xie XQ; Wang J
    ACS Chem Neurosci; 2020 Apr; 11(8):1139-1158. PubMed ID: 32196303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery.
    Gado F; Meini S; Bertini S; Digiacomo M; Macchia M; Manera C
    Future Med Chem; 2019 Aug; 11(15):2019-2037. PubMed ID: 31517528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators.
    Yuan J; Jiang C; Wang J; Chen CJ; Hao Y; Zhao G; Feng Z; Xie XQ
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs.
    Feng Z; Alqarni MH; Yang P; Tong Q; Chowdhury A; Wang L; Xie XQ
    J Chem Inf Model; 2014 Sep; 54(9):2483-99. PubMed ID: 25141027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB
    Aviz-Amador A; Contreras-Puentes N; Mercado-Camargo J
    Comput Biol Chem; 2021 Dec; 95():107590. PubMed ID: 34700256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding Characterization of GPCRs-Modulator by Molecular Complex Characterizing System (MCCS).
    Feng Z; Liang T; Wang S; Chen M; Hou T; Zhao J; Chen H; Zhou Y; Xie XQ
    ACS Chem Neurosci; 2020 Oct; 11(20):3333-3345. PubMed ID: 32941011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
    Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
    Showalter VM; Compton DR; Martin BR; Abood ME
    J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Allosteric Modulation of CB
    Scott CE; Kendall DA
    Methods Enzymol; 2017; 593():317-342. PubMed ID: 28750809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor.
    Iliff HA; Lynch DL; Kotsikorou E; Reggio PH
    J Comput Chem; 2011 Jul; 32(10):2119-26. PubMed ID: 21523790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569.
    Aderibigbe AO; Pandey P; Doerksen RJ
    J Biomol Struct Dyn; 2022 Aug; 40(13):5729-5747. PubMed ID: 33480332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
    Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational potential of allosteric modulators targeting the cannabinoid CB
    Lu D; Immadi SS; Wu Z; Kendall DA
    Acta Pharmacol Sin; 2019 Mar; 40(3):324-335. PubMed ID: 30333554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single Point Mutation Blocks the Entrance of Ligands to the Cannabinoid CB
    Casajuana-Martin N; Navarro G; Gonzalez A; Llinas Del Torrent C; Gómez-Autet M; Quintana García A; Franco R; Pardo L
    J Chem Inf Model; 2022 Nov; 62(22):5771-5779. PubMed ID: 36302505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universality of the Sodium Ion Binding Mechanism in Class A G-Protein-Coupled Receptors.
    Selvam B; Shamsi Z; Shukla D
    Angew Chem Int Ed Engl; 2018 Mar; 57(12):3048-3053. PubMed ID: 29405531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
    Latek D; Kolinski M; Ghoshdastider U; Debinski A; Bombolewski R; Plazinska A; Jozwiak K; Filipek S
    J Mol Model; 2011 Sep; 17(9):2353-66. PubMed ID: 21365223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.